Ping An Healthcare and Technology Performance dei guadagni passati
Il passato criteri di controllo 0/6
Ping An Healthcare and Technology ha registrato una crescita degli utili a un tasso medio annuo di 15.6%, mentre il settore Consumer Retailing ha registrato utili in crescita a un tasso medio annuo di 15.8%. I ricavi sono stati in diminuzione a un tasso medio annuo di 1.4%.
Informazioni chiave
15.6%
Tasso di crescita degli utili
17.1%
Tasso di crescita dell'EPS
| Consumer Retailing Crescita del settore | 28.3% |
| Tasso di crescita dei ricavi | -1.4% |
| Rendimento del capitale proprio | -0.2% |
| Margine netto | -0.5% |
| Ultimo aggiornamento sui guadagni | 30 Jun 2024 |
Aggiornamenti sulle prestazioni recenti
Recent updates
Ping An Healthcare and Technology Company Limited (HKG:1833) Stock Rockets 28% As Investors Are Less Pessimistic Than Expected
Nov 17
Ping An Healthcare and Technology Company Limited (HKG:1833) Stock Rockets 30% As Investors Are Less Pessimistic Than Expected
Sep 27Ping An Healthcare and Technology Company Limited (HKG:1833) Shares Could Be 49% Below Their Intrinsic Value Estimate
Sep 20Ping An Healthcare and Technology Company Limited's (HKG:1833) Share Price Not Quite Adding Up
Jul 17Revenues Not Telling The Story For Ping An Healthcare and Technology Company Limited (HKG:1833)
Apr 17Ping An Healthcare and Technology (HKG:1833) Is In A Strong Position To Grow Its Business
Mar 20Calculating The Fair Value Of Ping An Healthcare and Technology Company Limited (HKG:1833)
Jan 12Getting In Cheap On Ping An Healthcare and Technology Company Limited (HKG:1833) Is Unlikely
Dec 22We're Hopeful That Ping An Healthcare and Technology (HKG:1833) Will Use Its Cash Wisely
Sep 27A Look At The Intrinsic Value Of Ping An Healthcare and Technology Company Limited (HKG:1833)
Sep 10When Should You Buy Ping An Healthcare and Technology Company Limited (HKG:1833)?
Aug 02Here's Why We're Not Too Worried About Ping An Healthcare and Technology's (HKG:1833) Cash Burn Situation
Jun 26Ping An Healthcare and Technology Company Limited's (HKG:1833) Share Price Could Signal Some Risk
Jun 07Is There An Opportunity With Ping An Healthcare and Technology Company Limited's (HKG:1833) 46% Undervaluation?
Apr 04Should You Think About Buying Ping An Healthcare and Technology Company Limited (HKG:1833) Now?
Feb 16We Think Ping An Healthcare and Technology (HKG:1833) Can Afford To Drive Business Growth
Jan 23A Look At The Fair Value Of Ping An Healthcare and Technology Company Limited (HKG:1833)
Jan 02Companies Like Ping An Healthcare and Technology (HKG:1833) Are In A Position To Invest In Growth
Oct 11Estimating The Fair Value Of Ping An Healthcare and Technology Company Limited (HKG:1833)
Sep 14Companies Like Ping An Healthcare and Technology (HKG:1833) Are In A Position To Invest In Growth
Jun 22We're Hopeful That Ping An Healthcare and Technology (HKG:1833) Will Use Its Cash Wisely
Mar 01We're Not Very Worried About Ping An Healthcare and Technology's (HKG:1833) Cash Burn Rate
Nov 13Are Ping An Healthcare and Technology Company Limited (HKG:1833) Investors Paying Above The Intrinsic Value?
Oct 18Companies Like Ping An Healthcare and Technology (HKG:1833) Are In A Position To Invest In Growth
Aug 05Are Ping An Healthcare and Technology Company Limited (HKG:1833) Investors Paying Above The Intrinsic Value?
Jul 10We Think Ping An Healthcare and Technology (HKG:1833) Can Afford To Drive Business Growth
Apr 04If You Had Bought Ping An Healthcare and Technology (HKG:1833) Shares A Year Ago You'd Have Earned 47% Returns
Feb 28Are Institutions Heavily Invested In Ping An Healthcare and Technology Company Limited's (HKG:1833) Shares?
Jan 24
We Think Ping An Healthcare and Technology (HKG:1833) Can Easily Afford To Drive Business Growth
Dec 29Does This Valuation Of Ping An Healthcare and Technology Company Limited (HKG:1833) Imply Investors Are Overpaying?
Dec 03Ripartizione dei ricavi e delle spese
Ripartizione dei ricavi e delle spese
Come Ping An Healthcare and Technology guadagna e spende denaro. In base agli ultimi utili dichiarati, su base LTM.
Storia dei guadagni e delle entrate
| Data | Ricavi | Guadagni | Spese G+A | Spese di R&S |
|---|---|---|---|---|
| 30 Jun 24 | 4,545 | -21 | 1,871 | 0 |
| 31 Mar 24 | 4,609 | -172 | 2,094 | 0 |
| 31 Dec 23 | 4,674 | -323 | 2,317 | 0 |
| 30 Sep 23 | 5,135 | -370 | 2,480 | 0 |
| 30 Jun 23 | 5,596 | -418 | 2,643 | 0 |
| 31 Mar 23 | 5,901 | -527 | 2,756 | 0 |
| 31 Dec 22 | 6,205 | -636 | 2,869 | 0 |
| 30 Sep 22 | 6,276 | -879 | 2,950 | 0 |
| 30 Jun 22 | 6,347 | -1,121 | 3,032 | 0 |
| 31 Mar 22 | 6,841 | -1,330 | 3,318 | 0 |
| 31 Dec 21 | 7,334 | -1,538 | 3,603 | 0 |
| 30 Sep 21 | 7,636 | -1,576 | 3,524 | 0 |
| 30 Jun 21 | 7,938 | -1,614 | 3,445 | 0 |
| 31 Mar 21 | 7,402 | -1,281 | 3,024 | 0 |
| 31 Dec 20 | 6,866 | -948 | 2,604 | 0 |
| 30 Sep 20 | 6,203 | -812 | 2,564 | 0 |
| 30 Jun 20 | 5,539 | -675 | 2,524 | 0 |
| 31 Mar 20 | 5,302 | -704 | 2,403 | 0 |
| 31 Dec 19 | 5,065 | -734 | 2,282 | 0 |
| 30 Sep 19 | 4,777 | -737 | 2,294 | 0 |
| 30 Jun 19 | 4,488 | -740 | 2,306 | 0 |
| 31 Mar 19 | 3,913 | -826 | 2,270 | 0 |
| 31 Dec 18 | 3,338 | -912 | 2,233 | 0 |
| 30 Sep 18 | 3,082 | -1,182 | 2,129 | 0 |
| 30 Jun 18 | 2,542 | -990 | 1,684 | 0 |
| 31 Mar 18 | 2,205 | -996 | 1,542 | 0 |
| 31 Dec 17 | 1,868 | -1,002 | 1,400 | 0 |
| 30 Sep 17 | 1,319 | -641 | 1,211 | 0 |
| 31 Dec 16 | 601 | -758 | 1,241 | 0 |
| 31 Dec 15 | 279 | -324 | 423 | 0 |
Guadagni di qualità: 1833 al momento non è redditizia.
Margine di profitto in crescita: 1833 al momento non è redditizia.
Flusso di cassa libero e analisi degli utili
Analisi della crescita degli utili nel passato
Andamento degli utili: 1833 non è redditizia, ma ha ridotto le perdite negli ultimi 5 anni a un tasso pari a 15.6% all'anno.
Accelerare la crescita: Impossibile confrontare la crescita degli utili di 1833 nell'ultimo anno con la sua media quinquennale poiché al momento non è redditizia
Guadagni vs Settore: 1833 non è redditizia, il che rende difficile confrontare la crescita dei suoi utili dell'anno passato con il settore Consumer Retailing ( -7.2% ).
Rendimento del capitale proprio
ROE elevato: 1833 ha un Return on Equity negativo ( -0.22% ), in quanto al momento non è redditizio.